Humacyte, Inc.
$0.57
-0.03 (-5.15%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- -17.2%
- 3 Months
- -59.0%
- YTD
- -40.6%
- 1 Year
- -63.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 115.1%
- Largest decline max drawdown, since Aug 2025
- -77.8%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.29
Own HUMA?
See how HUMA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.